Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines

QR Code

Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines

The article discusses the 2022 updated version of the collaborative ASAS/EULAR (Assessment in SpondyloArthritis international Society/European Alliance of Associations for Rheumatology) recommendations for the treatment of axial spondyloarthritis.

Saved in:

Bibliographic Details
Main Authors:	Sh. F. Erdes, T. V. Dubinina
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2025-05-01
Series:	Научно-практическая ревматология
Subjects:	clinical guidelines axial spondyloarthritis biological therapy inhibitors of tumor necrosis factor alpha interleukin 17 inhibitors janus kinase inhibitors
Online Access:	https://rsp.mediar-press.net/rsp/article/view/3722
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

PROBLEMS IN THE THERAPY OF AXIAL SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR CONGRESS 2015 (ROME, 10–13 JUNE 2015)
by: O. A. Rumyantseva, et al.
Published: (2016-09-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-02-01)

How to treat a patient with psoriatic arthritis and chronic lymphocytic leukemia?
by: Jürgen Braun, et al.
Published: (2024-06-01)

Long-term efficacy and safety of netakimab in the treatment of ankylosing spondylitis: results of Phase III international, multicenter, randomized double-blind clinical trial BCD-085-5/ASTERA
by: V. I. Mazurov, et al.
Published: (2020-11-01)

Myeloid-derived suppressor cells as biomarkers of the effectiveness of therapy with new biological agents in axial spondyloarthritis
by: T. V. Tyrinova, et al.
Published: (2023-06-01)

LONG-TERM RETENTION RATE OF CERTOLIZUMAB PEGOL IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: DATA FROM THE TURKBIO REGISTRY
by: Ahmet Karataş, et al.
Published: (2025-06-01)

Kommentarii k novym rekomendatsiyam ASAS po ispol'zovaniyu ingibitorov faktora nekroza opukholi α pri aksial'nom spondiloartrite
by: Anna Georgiyevna Bochkova
Published: (2011-12-01)

TUMOR NECROSIS FACTOR-α INHIBITORS IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS
by: S. A. Lapshina, et al.
Published: (2016-09-01)

USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND BIOLOGICAL AGENTS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIDES. RECOMMENDATIONS OF THE SPONDYLOARTHRITIS STUDY GROUP OF EXPERTS, ALL-RUSSIAN PUBLIC ORGANIZATION «THE ASSOCIATION OF RHEUMATOLOGY OF RUSSIA»
by: I. Z. Gaidukova, et al.
Published: (2017-10-01)

Efficacy and safety of a new original interleukin 17A inhibitor in the treatment of patients with active ankylosing spondylitis: results of a basic (BCD-085-3/AILAS) and extended (BCD-085-3ext/AILAS-II) phase II clinical trial
by: Sh. Erdes, et al.
Published: (2019-12-01)

Psychiatric aspects of spondyloarthritis
by: T. A. Lisitsyna, et al.
Published: (2021-01-01)

Updating of lesion definitions and validation of MRI spinal lesions in patients with axial spondyloarthritis, conducted by the ASAS MRI working group
by: Shandor F. Erdes, et al.
Published: (2024-09-01)

Etanercept in axial spondyloarthritis – treatment efficacy
by: I. Z. Gaydukova, et al.
Published: (2022-03-01)

A NEW CONCEPT OF SPONDYLOARTHRITIS: A COMPROMISE BETWEEN ASAS AND GRAPPA?
by: Sh. F. Erdes
Published: (2018-01-01)

Experience with early use of certolizumab pegol in able-bodied patients with axial spondyloarthritis in the framework of a model for clinical statistical groups
by: Yu. Yu. Grabovetskaya
Published: (2020-09-01)

BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2020-06-01)

Differential diagnosis of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: E. E. Gubar, et al.
Published: (2025-06-01)

Axial spondyloarthritis—current aspects
by: Jürgen Braun, et al.
Published: (2024-07-01)

Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
by: Е. Е. Gubar, et al.
Published: (2024-04-01)

UPDATED ASAS-EULAR GUIDELINES FOR AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-12-01)

COMPARATIVE ANALYSIS OF MAIN CLINICAL MANIFESTATIONS IN MALES AND FEMALES WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumyantseva, et al.
Published: (2019-09-01)

«FLARES» IN AXIAL SPONDYLOARTHRITIS
by: Sh. F. Erdes
Published: (2016-07-01)

Axial spondyloarthritis: a current look at the concept and evolution of the disease
by: D. G. Rumyantseva, et al.
Published: (2019-10-01)

Features of the course and outcomes of COVID-19 in patients with axial spondyloarthritis
by: Sh. F. Erdes
Published: (2022-07-01)

Tofacitinib is a modern solution to the problem of resistant rheumatoid arthritis
by: I. V. Menshikova, et al.
Published: (2019-05-01)

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
by: Toshiki Okazaki, MD, et al.
Published: (2025-09-01)

Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature
by: Li B, et al.
Published: (2025-05-01)

ASSESSMENT OF COXITIS PROGRESSION IN EARLY AXIAL SPONDYLOARTHRITIS
by: E. M. Agafonova, et al.
Published: (2020-04-01)

Efficacy of golimumab in treating uveitis in patients with ankylosing spondylitis
by: T. V. Dubinina, et al.
Published: (2016-09-01)

DRAFT «ASPINE» MOBILE APPLICATION FOR PATIENTS WITH EARLY AXIAL SPONDYLOARTHRITIS
by: D. G. Rumiantceva, et al.
Published: (2018-01-01)

COVID-19 Therapy: the Role of Antirheumatic Drugs
by: M. A. Litvinova, et al.
Published: (2021-10-01)

Disease activity and two-year sacroiliac joint changes according to instrumental study findings in a CoRSAr cohort of patients with early axial spondyloarthritis
by: Sh. Erdes, et al.
Published: (2019-05-01)

Resolution of the Expert Council “New approaches to the treatment of axial spondyloarthritis”
by: A. M. Lila, et al.
Published: (2024-06-01)

Radiologic methods as a tool for monitoring axial spondyloarthritis in real clinical practice
by: T. V. Dubinina, et al.
Published: (2022-02-01)

HLA-B27-associated uveitis: From pathogenesis to therapy
by: A. B. Demina, et al.
Published: (2016-01-01)

Coxitis in early axial spondyloarthritis
by: E. M. Agafonova, et al.
Published: (2019-10-01)

Use of JAK Inhibitors in Lichen Planus: An Update
by: Dario Didona, et al.
Published: (2025-06-01)

Can Janus kinase inhibitors be used to treat immune checkpoint inhibitor associated adverse events?
by: Jürgen Braun, et al.
Published: (2024-11-01)

Progression of axial spondyloarthritis
by: Sh. F. Erdes, et al.
Published: (2021-06-01)

The use of selective Janus kinase inhibitor upadacitinib in a patient with psoriatic arthritis (clinical observation)
by: Yu. A. Lushpaeva
Published: (2025-04-01)